巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Vincerx Pharma

    VINC
    1.360
    0.050
    3.55%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Vincerx Pharma - 延遲價格・最後更新於 10/08 9:30
    最高位
    1.430
    最低位
    1.330
    開市價
    --
    前收市價
    1.410
    成交量(千)
    14.10
    成交額(百萬)
    0.17
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    28.64
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    18.427 - 1.260
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Vincerx Pharma
    證券代碼
    VINC.US
    所屬板塊
    Biotechnology
    公司業務
    Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform.
    發行量
    17505239
    公司總部
    260 Sheridan Avenue, Suite 400
    公司網址
    https://www.vincerx.com
    公司電話
    +1 650 800-6676
    暫無內容

    關於

    Vincerx Pharma(VINC.US)所屬的行業板塊為Biotechnology。
    Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform.
    詳細公司背景可參考: https://www.vincerx.com